BMS-986090 is a humanized monoclonal antibody antagonist targeting CD40. It shows potential for use in studying autoimmune diseases, such as systemic lupus erythematosus (SLE) and focal segmental glomerulosclerosis (FSGS).
Target:
TNF
* VAT and and shipping costs not included. Errors and price changes excepted
